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Trisomy 7 is a common finding in benign and 
malignant solid tumors, in several non-neoplastic 
lesions (for example, osteoarthritis and rheumatoid 
arthritis), and in apparently normal tissues as well. 
Trisomy 7 is found in both acute myeloid leukemia 
(AML) and acute lymphoblastic leukemia (ALL), but 
very rarely as the sole karyotypic abnormality. 
Clinics and pathology 
Disease 
Acute myeloid leukemia (AML) 
Epidemiology 
+7 as the sole anomaly is a rare chromosomal 
abnormality. Only four cases of AML with isolated 
trisomy 7 have been described in the literature. These 
cases show various FAB subtypes including M0, M5a, 
M1, and M4, and two cases of myelodysplastic 
syndrome (Hagemeijer et al., 1981; Leverger et al., 
1988; Bernell et al., 1996; Taketani et al., 2003). 
Clinics 
In the four reported cases of AML with trisomy 7, there 
is no clinical history, laboratory results, nor 
immunophenotypic studies available for analysis. The 
two cases of myelodysplastic syndrome with isolated 
trisomy 7 were a 77 year-old female patient diagnosed 
with myelodysplastic syndrome and a 75 year-old male 
patient with refractory anemia with excess blasts - 1 
(RAEB-1) who later developed acute myeloid 
leukemia. 
Prognosis 
Patients with trisomy 7 seem to have very poor 
prognosis with the survival time of five months and 
three months in AML cases. In the MDS cases one 
patient died three months after diagnosis.  
The second patient developed AML two months after 
the diagnosis of MDS and died four days after his AML 
was diagnosed. 
Disease 
Acute lymphoblastic leukemia (ALL) 
Epidemiology 
+7 is very rare as a sole chromosomal abnormality in 
ALL.  
Only three cases of ALL with isolated trisomy 7 have 
been previously described in the literature.  
Patient ages range from 8 months to 44 years old. No 
detailed clinical and pathological information is 
available for review (El-Rifai et al., 1997; Whitehead et 
al., 1998; Ameye et al., 2000). 
Prognosis 
The prognosis of ALL with trisomy 7 is unknown, 
largely due to the rarity and lack of follow up of this 
entity. 
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